Porphyria cutanea tarda and HIV/AIDS: A review of pathogenesis, clinical manifestations and management

International Journal of STD and AIDS

Volumn 10, Issue 1, 1999, Pages 51-56

  Mansourati, Fadi F ^a   Stone, Valerie E ^a,b   Mayer, Kenneth H ^a  

^a MEMORIAL HOSPITAL OF RHODE ISLAND   (United States)

^b BROWN UNIVERSITY   (United States)

Author keywords

AIDS; Human immunodeficiency virus; Porphyria cutanea tarda

Indexed keywords

DIDANOSINE; HEME; NELFINAVIR; SAQUINAVIR; STAVUDINE; UROPORPHYRINOGEN DECARBOXYLASE; ZIDOVUDINE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ARTICLE; CASE REPORT; CLINICAL FEATURE; ENZYME ACTIVITY; ERYTHROCYTE; FEMALE; HEME SYNTHESIS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MALE; PATHOGENESIS; PHLEBOTOMY; PORPHYRIA CUTANEA TARDA; PRIORITY JOURNAL;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ADULT; FEMALE; HIV INFECTIONS; HUMANS; MALE; MIDDLE AGED; PORPHYRIA CUTANEA TARDA;

EID: 0032907166     PISSN: 09564624     EISSN: None     Source Type: Journal    
DOI: 10.1258/0956462991912944     Document Type: Article

References (48)

1. 1 Bickers DR, Pathak MA, Lim HW. Porphyria cutanea tarda. In: Fitzpatrick T, Eisen A, Wolff K, Fredberg I, Frank Austin K, eds. Dermatology in General Medicine, 4th edn. 1993: 1872-81
2. 2 Novice FM, Collison DW, Burgdorf WHC, Esterly NB. Handbook of Genetic Skin Disorders. USA: WB Saunders, 1994:550-3
3. 3 Wissel PS, et al. Porphyria cutanea tarda associated with the acquired immune deficiency syndrome. Am J Hematol 1987;25:107-13
4. 4 Larnier C, Avenel M, Rousselet MC, et al. Hépatite granulomateuse a mycobactérie aviaire au cours d'un SIDA révèle par une porphyrie cutanée tardive. Gastroentérol Clin Biol 1987;11:264-5
5. 5 Conrad ME. AIDS and porphyria cutanea tarda. Am J Hematol 1988;28:207-8
6. 6 Lobato MN, Berger TG. Porphyria cutanea tarda associated with the acquired immunodeficiency syndrome. Arch Dermatol 1988;124:1009-10
7. 7 Ong ELC, Ellis ME, McDowell D, et al. Porphyria cutanea tarda in association with the human immunodeficiency virus infection. Postgrad Med J 1988;64:956-7
8. 8 Hogan D, Card RT, Ghadially R, et al. Human immunodeficiency virus infection and porphyria cutanea tarda. J Am Acad Dermatol 1989;20:17-20
9. 9 Nip-Sakamoto CJ, Wong RHW, Izumi AK. Porphyria cutanea tarda and AIDS. Cutis 1989;44:470-1
10. 10 Lacoma F, Yebra M, Albarran F, et al. Porphyria cutanea tarda and human immunodeficiency virus: two new cases. Postgrad Med J 1989;65:507
11. 11 Cohen PR, Suarez SM, DeLeo VA. Porphyria cutanea tarda in human immunodeficiency virus-infected patients. JAMA 1990;264:1315-16
12. 12 Lafeuillade A, Dhiver C, Martin I, et al. Porphyria cutanea tarda associated with HIV infection. AIDS 1990;4:924
13. 13 Massone L, Priano L, Pestarino A, et al. Porphyria cutanea tarda and HIV infection. AIDS 1990;4:925
14. 14 Enriquez de Salamanca R, Sanchez-Perez J, Diaz-Mora F, et al. Porphyria cutanea tarda associated with HIV infection: are those conditions pathogenetically related or merely coincidental? AIDS 1990;4:926-7
15. 15 Reynaud P, Goodfellow K, Svec F. Porphyria cutanea tarda as initial presentation of the acquired immunodeficiency syndrome in two patients. J Infect Dis 1990;161:1032-3
16. 16 Scannell KA. Porphyria cutanea tarda and acquired immunodeficiency syndrome: case reports and literature review. Arch Dermatol 1990;126:1658-9
17. 17 Adell Cullell MT, Llibre Codina JM, Vela Payan MD, Tor Aguilera J. Virus de la immunodeficiencia humana y porfiria cutánea tarda: una associación casual? Revista Clinica Española 1990;187:83-4
18. 18 Picard C, Crickx B, Fegueux S, et al. Porphyria cutanea tarda in HIV infection (abstract). International World Congress on AIDS, 1991
19. 19 Supapannachart N, Breneman D, Linnemann C. Isolation of human immunodeficiency virus type I in cutaneous blister fluid. Arch Dermatol 1991;127:1198-200
20. 20 Herranz MT, El Amrani A, Aranegui P. Porphyria cutanea tarda and acquired immunodeficiency syndrome: pathogenetic implications. Arch Dermatol 1990;126(12):1658-9
21. 21 Boisseau AM, Couzigou P, Forestier JF, et al. Porphyria cutanea tarda associated with human immunodeficiency virus infection: a study of four cases and review of the literature. Dermatologica 1991;182:155-9
22. 22 Cohen PR. Porphyria cutanea tarda in human immunodeficiency virus-seropositive men: case report and literature review. J Acquir Immune Defic Synd 1991;4:112-17
23. 23 Blauvelt A, Harris HR, Hogan DJ, et al. Porphyria cutanea tarda and human immunodeficiency virus infection. Int J Dermatol 1992;31:474-9
24. 24 Russel MGVM, Lustermans FATh, et al. Porphyria cutanea tarda in a patient with AIDS. Netherlands J Med 1992;41:68-70
25. 25 Pilar Garcia M, De Moragas JM. Porphyria cutanea tarda in an HIV-infected patient. Int J Dermatol 1992;31:435-6
26. 26 Huerter CJ, Kunkel JR, Stinson R. Porphyria cutanea tarda in association with human immunodeficiency virus (HIV) infection. Nebraska Med J 1993;78:155-7
27. 27 El Sayed F, Viraben R, Bazex J, Gorguet B. Porphyrie cutanée tardive et infection a VIH-1: deux nouveaux cas. Ann Dermatol Vénérol 1993;120:455-7
28. 28 Belda Mira A, Rovira Daudi E, et al. Porphyria cutanea tarda and human immunodeficiency virus infection. Apropos of 2 further cases (letter). Rev Clin Esp 1994;194:583-4
29. 29 Caminal Montero L, et al. Cutaneous hyperpigmentation in an HIV+ patient (letter). Rev Clin Esp 1994;194:319-20
30. 30 Castanet J, Lacour JPH, et al. Porphyria cutanea tarda in association with human immunodeficiency virus infection: is it related to hepatitis C virus infection? Arch Dermatol 1994;130:664-5
31. 31 Kemper Alston W. Porphyria cutanea tarda associated with human immunodeficiency virus infection. Clin Infect Dis 1995;21:1530
32. 32 McAlister F, McClean K, Hamilton R, Houston S. Human immunodeficiency virus and porphyria cutanea tarda: coexistence of risk factors or causative association? Clin Infect Dis 1995;20:348-51
33. 33 Berard F, Cotte L, Grezard P, Perrot H. Porphyrie cutanée tardive associée a l'infection par le VIH en l'absence de coinfection par le virus de l'hépatite C. La Presse Médicale 1996;25:1349
34. 34 Drobacheff C. Porphyria cutanea tarda (PCT) and HIV infection (abstract). XI International Conference on AIDS. Vancouver, 1996
35. 35 Pascual C, Garcia-Patos V, Bartralot R, et al. Pigmentation cutanée, seule manifestation d'une porphyrie cutanée tardive chez un malade séropositif pour le VIH-1, Ann Dermatol Vénérol 1996;123:262-4
36. 36 Martin-Vivaldi Martinez R, Espinosa Aguilar MD, et al. Associación entre porfiria cutánea tarda y virus de la hepatitis C. Rev Esp Enf Digest 1996;88:213-16
37. 37 Hoegl L, Thoma-Greber E, Rocken M. Porphyria cutanea tarda (type 1) bei HIV-infektion. Hautarzt 1996;47:58-61
38. 38 Ash S, Woodley DT, Chan LS. Porphyria cutanea tarda preceding AIDS. Lancet 1996;347:190
39. 39 Soriano E, Catala MT, Lacruz J, et al. Porfiria cutánea tarda e infección por el virus de la immunodeficiencia humana. Revista Clinica Española 1993;192:32-4
40. 40 Grossman ME, et al. Porphyria cutanea tarda. Clinical features and laboratory findings in 40 patients. Am J Med 1979;67:277
41. 41 Gregory N, DeLeo V. Clinical manifestations of photo-sensitivity in patients with human immunodeficiency virus infection. Arch Dermatol 1994;130:630-3
42. 42 Herrero C, Vincente A, Bruguera M, et al. Is hepatitis C virus infection a trigger of porphyria cutanea tarda? Lancet 1993;341:788-9
43. 43 Blauvelt A. Hepatitis C virus and human immunodeficiency virus infection can alter porphyrin metabolism and lead to porphyria cutanea tarda. Arch Dermatol 1996;132:1503-4
44. 44 English JC, Peake MF, Becker LE. Hepatitis C and porphyria cutanea tarda. Cutis 1996;57:404-8
45. 45 Siegel LB, Eber BB. Porphyria cutanea tarda remission. Ann Intern Med 1994;121:308-9
46. 46 Nomura N, Zolla-Pazner S, et al. Abnormal serum porphyrin levels in patients with the acquired immunodeficiency syndrome with or without hepatitis C virus infection. Arch Dermatol 1996;132:906-10
47. 47 O'Connor W, Murphy GM, et al. Porphyrin abnormalities in acquired immunodeficiency syndrome. Arch Dermatol 1996;132:1443-7
48. 48 Cribier B, Rey D, et al. Abnormal urinary coproporphyrin levels in patients infected by hepatitis C virus with or without human immunodeficiency virus. Arch Dermatol 1996;132:1449-52